234 related articles for article (PubMed ID: 2471709)
1. Human thyrotropin receptor subunits characterized by thyrotropin affinity purification and western blotting.
Leedman PJ; Newman JD; Harrison LC
J Clin Endocrinol Metab; 1989 Jul; 69(1):134-41. PubMed ID: 2471709
[TBL] [Abstract][Full Text] [Related]
2. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
4. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
5. The thyroid stimulating hormone receptor in human disease.
Harrison LC; Leedman PJ
Clin Biochem; 1990 Feb; 23(1):43-8. PubMed ID: 1691960
[TBL] [Abstract][Full Text] [Related]
6. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin.
Hoermann R; Amir SM; Nomura T; Ingbar SH
Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line.
Gennick SE; Thomas CG; Nayfeh SN
Endocrinology; 1987 Dec; 121(6):2119-30. PubMed ID: 3678141
[TBL] [Abstract][Full Text] [Related]
8. Antithyrotropin antibodies in the sera of Graves' disease patients.
Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
[TBL] [Abstract][Full Text] [Related]
9. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin purified from human and porcine thyroids inhibits thyrotropin binding to porcine thyroid cells.
Kouki T; Inui T; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A; Ozaki O; Ito K; Kurihara H
Thyroid; 1997 Dec; 7(6):943-8. PubMed ID: 9459642
[TBL] [Abstract][Full Text] [Related]
11. Solubilization, purification, and partial characterization of thyrotropin receptor from bovine and human thyroid glands.
Koizumi Y; Zakarija M; McKenzie JM
Endocrinology; 1982 Apr; 110(4):1381-91. PubMed ID: 6120830
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labelling of the porcine thyrotropin receptor--effect of Graves' immunoglobulin G and anti-TSH anti-idiotypic antibodies.
Bakó G; Islam MN; Farid NR
Clin Invest Med; 1985; 8(2):152-9. PubMed ID: 2870832
[TBL] [Abstract][Full Text] [Related]
13. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
14. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
[TBL] [Abstract][Full Text] [Related]
15. Expression of the functional extracellular domain of human thyrotropin receptor using a vaccinia virus system: its purification and analysis of autoantibody binding.
Lee MH; Park JY; Cho BY; Chae CB
J Clin Endocrinol Metab; 1999 Apr; 84(4):1391-7. PubMed ID: 10199784
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
Abe Y
Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin (TSH) receptor modulation by specific TSH receptor antibodies in Graves' disease.
de Bruin TW; Bussemaker JK; Heidema J; Hermans J; van der Heide D
J Clin Endocrinol Metab; 1988 Oct; 67(4):676-81. PubMed ID: 2901428
[TBL] [Abstract][Full Text] [Related]
18. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule.
Sugawa H; Akamizu T; Kosugi S; Ueda Y; Ohta C; Okuda J; Mori T
Eur J Endocrinol; 1995 Sep; 133(3):283-93. PubMed ID: 7581943
[TBL] [Abstract][Full Text] [Related]
19. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
